ResearcherNational Cancer InstituteActive in the last 2 years

Jonathan D. Ashwell

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-7386-8738; OpenAlex author ID A5037682468; NIH RePORTER profile ID 9692263.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 2
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 grant · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant

Papers 1

Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Last author DOI 10.1038/nm.3957 ↗

Grants 2

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Muhammad Shamsul Alam · 1 shared paper, 2015
- Paper Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progr… DOI 10.1038/nm.3957 ↗
Nathalia A. Giese · 1 shared paper, 2015
- Paper Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progr… DOI 10.1038/nm.3957 ↗
Thilo Hackert · 1 shared paper, 2015
- Paper Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progr… DOI 10.1038/nm.3957 ↗
Matthias M. Gaida · 1 shared paper, 2015
- Paper Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progr… DOI 10.1038/nm.3957 ↗
S. Perwez Hussain · 1 shared paper, 2015
- Paper Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progr… DOI 10.1038/nm.3957 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.